New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B

AIDS

Volumn 25, Issue 7, 2011, Pages 1013-1014

  Soriano, Vincent ^a   Vispo, Eugenia ^a   Barreiro, Pablo ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EMTRICITABINE; ENTECAVIR; LAMIVUDINE; PEGINTERFERON ALPHA; RIBAVIRIN; STAVUDINE; TELBIVUDINE; TENOFOVIR; ZIDOVUDINE;

CHRONIC HEPATITIS; DRUG MECHANISM; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIXED INFECTION; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT INDICATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; DRUG ADMINISTRATION SCHEDULE; HEPATITIS B, CHRONIC; HIV INFECTIONS; HUMANS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES;

EID: 79954576654     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328344fe96     Document Type: Note

References (4)

1. DHHS Panel. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. 2011. www.aidsinfo.nih. gov.
2. Soriano V, Vispo E, Labarga P, Medrano J, Barreiro P. Viral hepatitis and HIV co-infection. Antiviral Res 2010; 85:303-315.
3. Pessôa M, Gazzard B, Huang A, Brandão-Mello C, Cassetti I, Mendes-Corrêa M, et al. Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivu-dine as part of antiretroviral therapy. AIDS 2008; 22:1779-1787.
4. Vispo E, Barreiro P, PinedaJA, MiraJA, Maida I, Mart́n-Carbo-nero L, et al. Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir. Antivir Ther 2008; 13:429-437. (Pubitemid 352016736)